Crossmark

Anti-quorum, anti biofilm activity of FDA approved drugs against P. aeruginosa: in silico and in vitro studies

Published Online: 2026-02-10

Published Print: 2026-04

Authors

Kumar, Vivek

Srivastava, Anmol

Agarwal, Vishnu https://orcid.org/0000-0002-7060-4454
Funding

Funding for this research was provided by:

Indian Council of Medical Research (AMR/ADHOC/184/2019-ECD-II)
License Information

Text and Data Mining valid from 2026-02-10

Version of Record valid from 2026-02-10
More Information

Article History

Received: 23 June 2025

Revised: 12 December 2025

Accepted: 8 January 2026

First Online: 10 February 2026

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this study.

Document is current